JSM 2012 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program HomeActivity Details
|
|||
113 * ! | Mon, 7/30/2012, 8:30 AM - 10:20 AM | CC-Room 23A | |
Dose Selection in Clinical Trials — Topic Contributed Papers | |||
Biopharmaceutical Section , International Indian Statistical Association | |||
Organizer(s): Weihua Cao, FDA | |||
Chair(s): zhi wen, FDA | |||
8:35 AM | Simultaneous Inference for Dose Selection with Binary Responses — Bernhard Klingenberg, Williams College | ||
8:55 AM | Utility-Based Dose-Finding in Phase I-II Clinical Trials — Peter Thall, MD Anderson Cancer Center ; Hoang Q Nguyen, MD Anderson Cancer Center | ||
9:15 AM | Characterizing Dose-Response in the Development of Novel Treatments for Multiple Sclerosis — David I Ohlssen, Novartis | ||
9:35 AM | Designing Phase 2 Trials Based on Program-Level Criteria — Nitin Patel, Cytel Inc. ; James Bolognese, Cytel Inc. ; Christy Chuang-Stein, Pfizer Inc. ; David Hewitt, Merck ; Arnold Gammaitoni, Nuvo Research ; Jose Carlos Pinheiro, Johnson & Johnson | ||
9:55 AM | Discussant: Amelia Dale Horne, FDA | ||
10:15 AM | Floor Discussion |
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.